Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Huang I–A et al. – In this study, all patients with SAA received IST as standard front–line therapy. Approximately three–fourths of patients with SAA have durable recovery and excellent overall survival.

Related Articles

Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
International Journal of Hematology, 10/23/09    Relevance Score: 69%

Aplastic anemia in the orient
International Journal of Hematology, 10/07/09    Relevance Score: 67%

New advances in the treatment of acquired severe aplastic anaemia
International Journal of Hematology, 10/07/09    Relevance Score: 67%

The relationship of aplastic anemia and PNH
International Journal of Hematology, 10/07/09    Relevance Score: 67%

Comparative analysis of G-CSFR and GM-CSFR expressions on CD34+ cells in patients with aplastic anemia and myelodysplastic syndrome
International Journal of Laboratory Hematology, 10/28/09    Relevance Score: 65%

Today in Pediatric Heme/Oncology...keeping you current

Peripheral arterial tonometry in assessing endothelial dysfunction in pediatric sickle cell disease
Pediatric Hematology and Oncology, 11/25/09

Hepatoblastoma metastatic to the right atrium responding to chemotherapy alone
Pediatric Hematology and Oncology, 11/25/09

Association between defb1 gene haplotype and herpes viruses seroprevalence in children with acute lymphoblastic leukemia
Pediatric Hematology and Oncology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address